We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Comen Medical

Download Mobile App




Illustration

New Chest X-Ray Scoring System Can Be Used to Predict Outcome of COVID-19 Patients

Research has found that in the setting of high pretest probability of COVID-19 infection or with quick turnaround of rapid real-time reverse transcriptase-polymerase chain reaction (RT-PCR) COVID-19 test, chest X-ray (CXR) scoring can predict patient outcomes. More...
16 Apr 2021
Illustration

ECMO Can Be Used as `Salvage Therapy` for COVID-19 Patients with Acute Respiratory Distress Syndrome, Finds New Study

A large study has suggested survival benefit for severely ill COVID-19 patients treated with extracorporeal membrane oxygenation (ECMO). More...
15 Apr 2021
Image: Professor Imre Berger (Photo courtesy of University of Bristol)

Ground-Breaking 'Pan-Corona Antivirals' Could Stop SARS-CoV-2 in Its Tracks When Used at First Sign of COVID-19 Symptoms

Clinical trials will shortly be launched into pivotal, cost-effective antiviral treatments for COVID-19 following the discovery of a molecule which changes the shape of the SARS-CoV-2 spike protein and in so doing inhibits the virus’ ability to enter cells. More...
14 Apr 2021
Illustration

Regeneron's Antibody Cocktail Injection Prevents Symptomatic COVID-19 Among Individuals Exposed to SARS-CoV-2

Regeneron Pharmaceuticals, Inc. (Tarrytown, NY, USA) has announced positive data from two Phase 3 trials of recently infected asymptomatic COVID-19 patients, evaluating REGEN-COV (casirivimab with imdevimab) 1,200 mg administered via subcutaneous (SC) administration. More...
13 Apr 2021
Illustration

Blood Plasma Biomarker Discovered in Hospitalized COVID-19 Patients May Predict ARDS Severity

A blood plasma biomarker discovered in hospitalized COVID-19 patients may not only predict the severity of adult respiratory distress syndrome (ARDS) but further research may lead to inhibiting the progression. More...
12 Apr 2021
Illustration

Portable Nasal Spray That Destroys SARS-CoV-2 Could Prove to Be Breakthrough COVID-19 Treatment

A self-administered nasal spray application that was found to have reduced SARS-CoV-2 log viral load by more than 95% in infected participants within 24 hours of treatment, and by more than 99% in 72 hours could prove to be a breakthrough treatment for COVID-19. More...
12 Apr 2021
Image: X-ray crystallographic structure of SARS-CoV-2 main protease (Photo courtesy of University of British Columbia)

Landmark Discovery of Critical SARS-CoV-2 Enzyme in First Ever X-Ray Images Could Improve Design of New COVID-19 Drugs

For the first time, a team of researchers has captured X-ray images of a critical enzyme of the COVID-19 virus performing its function. This discovery could improve design of new treatments against the disease. More...
09 Apr 2021
Copyright © 2000-2021 Globetech Media. All rights reserved.